Two Sigma Securities’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Two Sigma Securities’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,264	Closed	-$575	–	1485
2025 Q3	$575	Sell	18,264 -35,231	-66%	-$1.37K	﹤0.01%	1300
2025 Q2	$4.03K	Buy	53,495 +22,657	+73%	+$2.05K	﹤0.01%	1371
2025 Q1	$3.14K	Buy	+30,838	New	+$4.27K	﹤0.01%	1330

Other funds holding BCTXW

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

RAM

Redmond Asset Management Henrico, Virginia $401M AUM 14.95% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

NFSG

Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return

Two Sigma Securities's BCTXW Position: Q4 2025 in Review

Two Sigma Securities sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q4 2025, closing a stake of 18,264 shares — an estimated $575 sold.

Two Sigma Securities first reported a position in BCTXW in Q1 2025 and held it in 3 quarters. The position peaked at $4.03K in Q2 2025. 7 funds tracked by Wall St. Rank hold BCTXW as of Q4 2025.

Two Sigma Securities reported no remaining BriaCell Therapeutics Corp Warrant position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 18,264 BriaCell Therapeutics Corp Warrant shares in Q4 2025, an estimated $575.
Two Sigma Securities first reported a position in BriaCell Therapeutics Corp Warrant in Q1 2025 and held it in 3 quarters.
Two Sigma Securities's BriaCell Therapeutics Corp Warrant position peaked at $4.03K in Q2 2025.
7 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.